Modigliani, R <br/><br/>
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.  [electronic resource] 

 -  Gastroenterology  Mar 1996 
 - 688-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0016-5085 
<br/><br/><label>Standard No.: </label>10.1053/gast.1996.v110.pm8608877  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aminosalicylic Acids--therapeutic use<br/>Anti-Inflammatory Agents--administration & dosage<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Belgium<br/>Chi-Square Distribution<br/>Crohn Disease--drug therapy<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>France<br/>Humans<br/>Logistic Models<br/>Male<br/>Mesalamine<br/>Prednisolone--administration & dosage<br/>Proportional Hazards Models<br/>Recurrence<br/>Remission Induction